Table 3.

Clinical factors of hypertensive patients attending at the chronic follow-up clinic at Northwest Ethiopia referral hospitals.

Factors	Category	Frequency	Percentage
DBP	<90	527	90.7
	≥90	54	9.3
SBP	<140	517	89.0
	≥140	64	11.0
Duration of HTN (years)	<10	550	94.7
	≥10	31	5.3
BMI	<18.5	15	2.6
	18.5–24.9	429	73.8
	25–29.9	94	16.2
	>30	43	7.4
Stage of HTN	Stage I	262	45.1
	Stage II	288	49.6
	Stage III	31	5.3
Comorbid disease	No	360	62.0
	Yes	221	38.0
Family Hx of HTN	No	541	93.1
	Yes	40	6.9
Drugs other than anti-HTN Rx	No	373	64.2
	Yes	208	35.8
Proteinuria	No	488	84.0
	Yes	93	16.0
Dyslipidemia	No	436	75.0
	Yes	145	25.0
Body swelling	No	522	89.8
	Yes	59	10.2
ACE inhibitor	No	297	51.1
	Yes	284	48.9
Beta-blocker	No	525	90.4
	Yes	56	9.6
Diuretics	No	329	56.6
	Yes	252	43.4
Calcium channel blocker	No	187	32.2
	Yes	394	67.8
Vasodilator	No	462	79.5
	Yes	119	20.5